Schedule 13D ownership disclosure
INTERCEPT PHARMACEUTICALS IN
Security class unavailable · CUSIP: 45845P108
Event date: 2014-04-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.2300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000914121-14-000217
- Form type
- SC 13D
- Filer
- INTERCEPT PHARMACEUTICALS, INC.
- CIK
- CIK 1270073
- Filed
- Apr 11, 2014
- Reporting period
- Apr 09, 2014
- Description
- Schedule 13D beneficial ownership